A replacement inhaler has been before the Food and Drug Administration's approval board for some time, but the FDA has taken no action to allow for another over-the-counter inhaler to be available for consumers.
Burgess criticizes the FDA for delays in approving a new asthma inhaler.
Share
More from Michael Burgess
I urge adoption of the amendment. It is important, with $31 trillion in national debt, that we be good stewards of taxpayer dollars. The gentleman is right. I have pursued this for a number of years, but it is because it is a noble cause…
For the purpose of debate only, I yield the customary 30 minutes to the gentleman from Massachusetts (Mr. McGovern), pending which I yield myself such time as I may consume. During consideration of this resolution, all time yielded is for…
I led a letter to the FDA asking them to reclassify naloxone to where you could get it without a prescription.
This is a national emergency. This is something we have got to address and save Americans, 200 every day.
Other voices in this conversation
